Earnings Coverage

VRTX earnings

Vertex Pharmaceuticals Incorpor · Healthcare

Next earnings
Monday, August 3, 2026
Reports in 5 weeks
Heading in
Price
$491.34
Day Change
+232.41%
Market Cap
$124.7B
Revenue (TTM)
$12.22B

Recent quarterly results

Most recent 5 quarters

Revenue -636.7% QoQ
Period
Revenue
Gross Profit
Net Income
Q1 2026
$2.99B
$2.59B
$1.03B
Q4 2025
$3.19B
$2.72B
$1.19B
Q3 2025
$3.08B
$2.66B
$1.08B
Q2 2025
$2.96B
$2.56B
$1.03B
Q1 2025
$2.77B
$2.41B
$646.3M

VRTX earnings — common questions

When is Vertex Pharmaceuticals Incorpor's next earnings date?

Vertex Pharmaceuticals Incorpor (VRTX) is next scheduled to report earnings on Monday, August 3, 2026. That is roughly 36 days away.

What is the EPS estimate for VRTX?

Analysts expect earnings per share of about 21.47 for Vertex Pharmaceuticals Incorpor's upcoming quarter.

How often does Vertex Pharmaceuticals Incorpor report earnings?

Like most US-listed companies, Vertex Pharmaceuticals Incorpor reports earnings once per quarter — four times a year. The quarterly table above tracks its most recent results.

What was Vertex Pharmaceuticals Incorpor's most recent quarterly revenue?

In its most recent reported quarter (Q1 2026), Vertex Pharmaceuticals Incorpor posted revenue of about $2.99B.

Is Vertex Pharmaceuticals Incorpor's revenue growing?

Quarter over quarter, Vertex Pharmaceuticals Incorpor's revenue declined by 6.4% in the latest reported period. Quarterly readings can be seasonal, so the multi-quarter trend above gives the fuller picture.

Stay ahead of VRTX earnings.

Add VRTX to your watchlist for earnings alerts, the morning market brief covering the print, and AI-driven setup analysis around the date.

Free unlock
Turn earnings pages into alerts instead of bookmarks.

Save baskets, track next reports, and move from public catalyst pages into a repeatable watchlist workflow.